Sarepta Therapeutics (SRPT) Free Cash Flow Growth (1y) (2011 - 2026)
Sarepta Therapeutics (SRPT) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sarepta Therapeutics |
1.84 Bn |
1.16 Bn |
291.52 Mn |
67.35% |
| Date | Value |
|---|
| Mar 31, 2026 |
67.35% |
| Dec 31, 2025 |
136.48% |
| Sep 30, 2025 |
65.25% |
| Jun 30, 2025 |
1,713.64% |
| Mar 31, 2025 |
-128.43% |
| Dec 31, 2024 |
173.23% |
| Sep 30, 2024 |
25.22% |
| Jun 30, 2024 |
89.85% |
| Mar 31, 2024 |
-25.42% |
| Dec 31, 2023 |
26.57% |
| Sep 30, 2023 |
-97.25% |
| Jun 30, 2023 |
-84.66% |
| Mar 31, 2023 |
-105.09% |
| Dec 31, 2022 |
-218.27% |
| Sep 30, 2022 |
45.20% |
| Jun 30, 2022 |
34.03% |
| Mar 31, 2022 |
47.04% |
| Dec 31, 2021 |
84.48% |
| Sep 30, 2021 |
49.31% |
| Jun 30, 2021 |
9.25% |
